Related Experiment Videos
Clinical benefits of a consistent reduction in blood pressure
G Mancia1, B M Cattaneo, S Omboni
1Cattedra di Medicina Interna I, Ospedale S. Gerardo dei Tintori, Monza, Universita di Milano, Italy.
Insights
Hypertension significantly increases cardiovascular risk. Antihypertensive treatments reduce risk, but long-acting medications improve adherence and offer better protection against cardiovascular events and end-organ damage.
Area of Science:
- Cardiology
- Epidemiology
- Pharmacology
Background:
- Hypertension is a primary risk factor for cardiovascular disease.
- Epidemiological studies confirm the link between high blood pressure and adverse cardiovascular outcomes.
Purpose of the Study:
- To review evidence on hypertension as a cardiovascular risk factor.
- To summarize trial data on antihypertensive treatment efficacy.
- To discuss strategies for enhancing protection in hypertensive patients.
Main Methods:
- Review of epidemiological evidence.
- Analysis of data from controlled intervention trials.
- Discussion of therapeutic strategies and drug characteristics.
Main Results:
- Antihypertensive treatment demonstrably reduces cardiovascular morbidity and mortality.
- Current treatments do not provide complete protection.
- 24-hour blood pressure control and long-acting drugs enhance benefits.
Conclusions:
- Optimizing antihypertensive therapy is crucial for reducing cardiovascular events.
- Long-acting antihypertensive medications improve patient compliance and longevity of effect.
- Strategies focusing on 24-hour blood pressure control are vital for comprehensive patient protection.
Abstract:
This paper briefly reviews the epidemiological evidence that hypertension is a major cardiovascular risk factor. It also summarizes the data from controlled intervention trials that show antihypertensive treatment to be accompanied by a reduction in cardiovascular morbidity and mortality. The inability of antihypertensive treatment to offer full protection to the hypertensive individual is then discussed, together with the therapeutic strategies to increase the benefits, particularly with respect to limiting end-organ damage and reduction of cardiovascular events. In this context, emphasis is given to the potential additional benefit conferred by control of 24-h blood pressure and to the compliance advantage of using drugs with a long duration of action. The longevity of the blood pressure lowering effect can compensate for delayed or missed drug consumption, a frequent phenomenon in the chronically treated hypertensive patient.